US Stock MarketDetailed Quotes
MYCOF Mydecine Innovations
- 0.003800
- -0.018290-82.80%
15min DelayTrading Apr 29 09:51 ET
199.76KMarket Cap-4P/E (TTM)
0.003800High0.003800Low110Volume0.003800Open0.022090Pre Close0.42Turnover0.00%Turnover RatioLossP/E (Static)52.57MShares0.29000052wk High-0.04P/B30.97KFloat Cap0.00010052wk Low--Dividend TTM8.15MShs Float110.000000Historical High--Div YieldTTM0.00%Amplitude0.000100Historical Low0.003000Avg Price1Lot Size
Mydecine Innovations Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 98.18%-23.12K | 47.09%-2.15M | -85.05%-3M | 66.30%-8.13M | 81.34%-1.18M | 73.66%-1.27M | 4.00%-4.05M | 81.46%-1.62M | -237.11%-24.12M | -100.23%-6.32M |
| Net income from continuing operations | 59.78%-1.18M | -21.73%-3.18M | -35.77%-7.65M | 26.89%-17.24M | 47.29%-6.05M | -331.63%-2.94M | 68.67%-2.61M | -11.99%-5.64M | 12.25%-23.58M | 2.46%-11.48M |
| Operating gains losses | -84.93%1.81K | 184.49%533.77K | 154.86%2.28M | -766.59%-198.84K | -179.64%-472.55K | 103.25%12.02K | -182.28%-631.76K | 2,880.65%893.45K | 106.34%29.83K | -27.75%593.35K |
| Depreciation and amortization | -95.36%1.2K | -89.96%3.4K | -91.31%5.28K | -45.21%128.86K | -92.14%8.53K | -45.84%25.76K | -9.99%33.9K | 46.08%60.67K | 312.01%235.18K | 209.08%108.41K |
| Other non cash items | -55.68%246.92K | 13.11%239.62K | 4.73%234.92K | 214.59%973.47K | -134.30%-19.75K | 2,215.60%557.06K | 659.39%211.86K | 12.20%224.3K | -97.14%309.44K | -98.65%57.58K |
| Change In working capital | -15.29%909.91K | 124.58%259.32K | -70.01%851K | 278.75%8.21M | 486.95%5.35M | 165.86%1.07M | -1,081.66%-1.05M | 171.27%2.84M | -357.00%-4.59M | -55.20%912.13K |
| -Change in receivables | -3.21%21.35K | 699.06%231.15K | 111.07%9.01K | 5.88%-179.94K | -353.30%-149.57K | 115.10%22.05K | 453.69%28.93K | -1,945.51%-81.35K | -3,027.47%-191.18K | -262.68%-33K |
| -Change in prepaid assets | -84.00%275.52K | 139.82%435.83K | -48.19%602.5K | 166.74%3.4M | 307.33%1.61M | 216.66%1.72M | -333.65%-1.09M | 130.87%1.16M | -6,219.74%-5.1M | -39.17%395.9K |
| -Change in payables and accrued expense | 191.50%613.05K | -3,957.18%-407.67K | -86.36%239.5K | 615.86%4.99M | 608.39%3.89M | -6,978.74%-670K | -97.13%10.57K | 929.62%1.76M | -62.82%696.74K | -59.83%549.23K |
| Cash from discontinued investing activities | -550.19%-300.69K | -104.46%-69.99K | 119.96%66.79K | 1.57M | ||||||
| Operating cash flow | 98.46%-23.12K | 47.09%-2.15M | -85.05%-3M | 64.96%-8.43M | 73.72%-1.25M | 76.25%-1.5M | 4.60%-4.05M | 81.41%-1.62M | -237.61%-24.05M | -52.05%-4.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 25.2K | 500K | 92.07%-37.54K | 55.37%-37.54K | 0 | 0 | 0 | 17.41%-473.58K | 82.22%-84.11K |
| Net PPE purchase and sale | ---- | ---- | ---- | 91.23%-35.47K | ---- | ---- | ---- | ---- | 2.04%-404.32K | 59.98%-26.91K |
| Net business purchase and sale | ---- | ---- | ---- | ---2.08K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --0 | --25.2K | --500K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.45%-69.26K | 89.86%-57.2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --25.2K | --500K | 92.07%-37.54K | 55.37%-37.54K | --0 | --0 | --0 | 17.41%-473.58K | 82.22%-84.11K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -97.99%25K | -48.66%2.13M | 539.53%2.5M | -70.71%6.98M | -74.49%1.21M | 124.84%1.24M | 1,034.95%4.14M | -97.85%390.91K | 140.15%23.83M | -9.26%4.74M |
| Net issuance payments of debt | --0 | --0 | --0 | -98.67%73.14K | 100.36%35.65K | -100.02%-3.3K | ---94.33K | --135.13K | 19.57%5.5M | ---9.83M |
| Net common stock issuance | -97.99%25K | -52.86%2.13M | 581.82%2.5M | -54.95%6.91M | --788.75K | --1.24M | --4.51M | -97.61%366.67K | 226.90%15.33M | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 493.90%3.76M | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --35.64K | ---273.94K | ---110.88K | ---759.72K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.04%25K | -48.66%2.13M | 539.53%2.5M | -70.71%6.98M | -75.24%1.17M | 131.30%1.28M | 1,034.95%4.14M | -97.85%390.91K | 140.15%23.83M | -9.26%4.74M |
| Net cash flow | ||||||||||
| Beginning cash position | -87.52%40.46K | -96.11%10.29K | -99.26%11.03K | -31.74%1.5M | -94.42%88.93K | -95.39%324.15K | -97.66%264.68K | -31.74%1.5M | 11,930.87%2.19M | 156.82%1.59M |
| Current changes in cash | 91.14%-23.12K | -64.61%30.17K | 99.94%-739 | -113.45%-1.48M | 20.29%-77.9K | 95.20%-260.99K | 101.98%85.24K | -113.47%-1.23M | -131.25%-695.39K | -106.02%-97.73K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | 5,225.62%25.78K | ---- | ---- | ---- | ---- |
| End cash Position | -80.50%17.34K | -87.52%40.46K | -96.11%10.29K | -99.26%11.03K | -99.26%11.03K | -94.42%88.93K | -95.39%324.15K | -97.66%264.68K | -31.74%1.5M | -31.74%1.5M |
| Free cash flow | 98.46%-23.12K | 47.09%-2.15M | -85.05%-3M | 65.39%-8.46M | 73.12%-1.28M | 74.89%-1.5M | 12.85%-4.05M | 82.06%-1.62M | -219.72%-24.46M | -57.46%-4.78M |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
